|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. 11. Petricciani, John, M.D., Director, Food and Drug Administration, Office of Biologics. Letter to all establishments collecting source plasma; March 24, 1983. 12. Petricciani, John, M.D., Director, Food and Drug Administration, Office of Biologics. Letter to All licensed manufacturers of plasma derivatives; March 24, 1983. 13. National Hemophilia Foundation. Medical Bulletin #7: NHF Urges Clotting Factor Use Be Maintained; May 11, 1983. 14. American Association of Blood Banks, American Red Cross, and Council of Community Blood Centers. Joint Statement on Directed Donations and AIDS; June 22, 1983. 15. Donohue, Dennis, M.D., Director, Food and Drug Administration, Division of Blood and Blood Products. Memorandum to John Petricciani, M.D., Director, Food and Drug Administration, Office of Biologics; July 21, 1983. 16. Reilly, Robert, Executive Director, American Blood Resources Association. Letter to John C. Petricciani, Director, Food and Drug Administration, Office of Biologics; July 27, 1983.
|
|
|||||||||||||||
